Peptide History intermediate
History of Peptide Clinical Development
The evolution of peptide drugs through clinical trials from insulin to modern therapeutics. This peptide or oligopeptide is studied for its biological activi...
By Encyclopeptide Editorial | 1 min read
clinical development trials history
Overview
Peptide clinical development has progressed from simple hormone replacements to sophisticated targeted therapies across multiple disease areas.
Milestones
- 1922: First insulin clinical use
- 1970s: GnRH agonists in cancer trials
- 1980s: Cyclosporine transplant trials
- 1990s: Enfuvirtide HIV trials
- 2000s: Exenatide diabetes trials
- 2010s: GLP-1 obesity trials
- 2020s: Peptide drug conjugate trials
Challenges
Short half-life, injection delivery, and manufacturing complexity have historically limited peptide clinical development.
Advances
PEGylation, lipidation, and novel delivery technologies have overcome many historical limitations.
References
- Source: ENCP Peptide Database
- Category: Peptide History
Test Your Knowledge
Reinforce what you learned about History of Peptide Clinical Development with interactive quizzes on Wikipept.
Take a Quiz on Wikipept